Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The successful analysis of physiological processes requires quantitative understanding of the functional interactions between the key components of cells, organs and systems, and how these interactions change in disease states. This information does not reside in the genome, or even in the individual proteins that genes code for. There is therefore no alternative to copying nature and computing these interactions to determine the logic of healthy and diseased states. The rapid growth in biological databases, models of cells, tissues and organs, and in computing power has made it possible to explore functionality all the way from the level of genes to whole organs and systems. Examples are given of genetic modifications of the Na+ channel protein in the heart that predispose people to ventricular fibrillation, and of multiple target therapy in drug development. Complexity in biological systems also arises from tissue and organ geometry. This is illustrated using modelling of the whole heart.

Type

Journal article

Journal

Novartis Found Symp

Publication Date

2001

Volume

239

Pages

111 - 123

Keywords

Animals, Anti-Arrhythmia Agents, Biochemical Phenomena, Biochemistry, Computer Simulation, Gene Expression, Genome, Heart Failure, Humans, Models, Biological, Mutation, Nonlinear Dynamics, Physiology, Proteins, Proteome